Sign In  |  Register  |  About Burlingame  |  Contact Us

Burlingame, CA
September 01, 2020 10:18am
7-Day Forecast | Traffic
  • Search Hotels in Burlingame

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:

Patterson Companies Reports Fiscal 2023 Third Quarter Operating Results

  • Reported net sales increased 0.3 percent year-over-year to $1.6 billion, and internal sales increased 1.8 percent.
  • Drove adjusted operating margin expansion for business overall and within both Dental and Animal Health segments.
  • Delivered third quarter GAAP earnings of $0.55 per diluted share and adjusted earnings1 of $0.62 per diluted share, an increase of 13 percent over prior year.
  • Narrowed fiscal 2023 GAAP earnings guidance to $1.96 to $2.01 per diluted share and adjusted earnings1 guidance to $2.25 to $2.30 per diluted share.

Patterson Companies, Inc. (Nasdaq: PDCO) today reported consolidated net sales of $1.60 billion (see attached Sales Summary for further details) in its fiscal third quarter ended January 28, 2023, an increase of 0.3 percent compared to the same period last year. Internal sales, which are adjusted for the effects of currency translation and contributions from recent acquisitions, increased 1.8 percent over the prior year period.

Reported net income attributable to Patterson Companies, Inc. for the third quarter of fiscal 2023 was $53.9 million, or $0.55 per diluted share, compared to $57.0 million, or $0.58 per diluted share, in the third quarter of fiscal 2022. The year-over-year decrease in reported net income attributable to Patterson Companies, Inc. is related to an investment gain in the prior year period. Adjusted net income1 attributable to Patterson Companies, Inc., which excludes deal amortization and gains on investments, totaled $61.1 million for the third quarter of fiscal 2023, or $0.62 per diluted share, compared to $54.2 million, or $0.55 per diluted share, in the third quarter of fiscal 2022. The year-over-year increase in adjusted net income attributable to Patterson Companies, Inc. in the third quarter of fiscal 2023 is primarily due to operating margin expansion in both business segments.

“Our team continued to successfully execute during the third quarter and create value for both our customers and shareholders,” said Don Zurbay, President and CEO of Patterson Companies. “In addition to sales growth as a result of our strong value proposition to customers, our strategic focus on operational excellence, improved mix and disciplined expense management helped drive operating margin expansion for the business and within both segments during the fiscal third quarter. Our guidance reflects confidence in our ability to achieve our goals to deliver year-over-year internal sales growth and adjusted operating margin expansion in fiscal 2023.”

Patterson Dental

Reported net sales in the Dental segment for the third quarter of fiscal 2023 were $621.8 million. Internal sales decreased 3.8 percent compared to the fiscal 2022 third quarter. Internal sales of consumables declined 1.5 percent year-over-year primarily due to the continued moderation of infection control products compared to the pandemic-related performance in the year-ago period. Excluding infection control products, internal sales of consumables increased 4.6 percent year-over-year. Compared to the prior year period, internal sales of equipment decreased 9.7 percent driven by a decline in digital and CAD/CAM technology products. Internal sales of value-added services increased 4.5 percent.

Patterson Animal Health

Reported net sales in the Animal Health segment for the third quarter of fiscal 2023 were $969.4 million. Internal sales growth of 4.6 percent year-over-year was driven by sales growth in both companion animal and production animal. Within the Animal Health segment, internal sales of consumables grew 4.4 percent, equipment and software increased 2.8 percent and value-added services increased 31.0 percent compared to the prior year period.

Balance Sheet and Capital Allocation

During the first nine months of fiscal 2023, Patterson Companies used $728.2 million of cash from operating activities and collected deferred purchase price receivables of $758.0 million, generating $29.8 million in cash, compared to generating $84.2 million in the prior year period. Free cash flow1 (see definition below and attached free cash flow table) during the first nine months of fiscal 2023 declined by $70.4 million compared to the first nine months of fiscal 2022 due to an increased level of working capital during the first nine months of fiscal 2023.

In the third quarter of fiscal 2023, Patterson Companies declared a quarterly cash dividend of $0.26 per share and returned $25.2 million in cash dividends to shareholders. Through the first nine months of fiscal 2023, Patterson Companies has returned $91.0 million to shareholders through cash dividends and share repurchases.

Year-to-Date Results

Consolidated reported net sales for the first nine months of fiscal 2023 totaled $4.8 billion, a 2.3 percent year-over-year decrease. Sales in the first nine months of fiscal 2022 reflected an extra week of sales results in the first quarter of fiscal 2022. Internal sales for the first nine months of fiscal 2023, which are adjusted for the effects of currency translation, the extra week of selling results in the first quarter of fiscal 2022 and contributions from recent acquisitions, increased 1.8 percent year-over-year. Through the first nine months of fiscal 2023, Dental segment internal sales decreased 1.1 percent, including a 3.1 percent decline in consumables, a 0.2 percent decline in equipment and software and a 6.2 percent increase in value added services. Through the first nine months of fiscal 2023, Animal Health segment internal sales increased 3.5 percent, including 3.3 percent growth in consumables, 3.7 percent growth in equipment and software and a 15.0 percent increase in value added services.

Reported net income attributable to Patterson Companies, Inc. for the first nine months of fiscal 2023 was $132.6 million, or $1.35 per diluted share, compared to $139.3 million, or $1.42 per diluted share in last year's period. Adjusted net income1 attributable to Patterson Companies, Inc., which excludes deal amortization, integration and business restructuring expenses, legal reserves, inventory donation charges and gains on investments totaled $154.0 million for the first nine months of fiscal 2023, or $1.57 per diluted share, compared to $153.3 million, or $1.56 per diluted share, in the year-ago period.

Fiscal 2023 Guidance

Patterson Companies today narrowed its fiscal 2023 earnings guidance, which is provided on both a GAAP and non-GAAP adjusted1 basis:

  • GAAP earnings are expected to be in the range of $1.96 to $2.01 per diluted share.
  • Non-GAAP adjusted earnings1 are expected to be in the range of $2.25 to $2.30 per diluted share.
  • Our non-GAAP adjusted earnings1 guidance excludes the after-tax impact of:
    • Deal amortization expenses of approximately $29.2 million ($0.29 per diluted share).

Our guidance reflects the strength of our business and competitive positioning, as well as our expectations for the North American and international end markets in which we operate, which we expect to be affected by the ongoing challenges of inflationary trends and higher interest rates as well as a potential slow-down in the broader economy. Beyond macroeconomic and geopolitical uncertainty, our guidance further assumes that there are no material adverse developments associated with the pandemic.

1Non-GAAP Financial Measures

The Reconciliation of GAAP to non-GAAP Measures table appearing behind the accompanying financial information is provided to adjust reported GAAP measures, namely operating income, other income (expense), net income before taxes, income tax expense, net income, net income attributable to Patterson Companies, Inc. and diluted earnings per share attributable to Patterson Companies, Inc., for the impact of deal amortization, integration and business restructuring expenses, legal reserves, inventory donation charges and gains on investments along with the related tax effects of these items.

The term “free cash flow” used in this release is defined as net cash used in operating activities less capital expenditures plus the collection of deferred purchase price receivables.

In addition, the term “internal sales” used in this release represents net sales adjusted to exclude the impact of foreign currency, the extra week of selling results in the first quarter of fiscal 2022 and the impact from recent acquisitions. Foreign currency impact represents the difference in results that is attributable to fluctuations in currency exchange rates the company uses to convert results for all foreign entities where the functional currency is not the U.S. dollar. The company calculates the impact as the difference between the current period results translated using the current period currency exchange rates and using the comparable prior period's currency exchange rates. The company believes the disclosure of net sales changes in constant currency provides useful supplementary information to investors in light of fluctuations in currency rates.

Management believes that these non-GAAP measures may provide a helpful representation of the company's third quarter performance and enable comparison of financial results between periods where certain items may vary independent of business performance. These non-GAAP financial measures are presented solely for informational and comparative purposes and should not be regarded as a replacement for corresponding, similarly captioned, GAAP measures.

Third Quarter Conference Call and Replay

Patterson Companies’ fiscal 2023 third quarter conference call will start at 8:30 a.m. Eastern today. Investors can listen to a live webcast of the conference call at www.pattersoncompanies.com. The conference call will be archived on the Patterson Companies website. A replay of the fiscal 2023 third quarter conference call can be heard for one week at 1-800-770-2030 and by providing the Conference ID 71954 when prompted.

About Patterson Companies Inc.

Patterson Companies Inc. (Nasdaq: PDCO) connects dental and animal health customers in North America and the U.K. to the latest products, technologies, services and innovative business solutions that enable operational and professional success. Our comprehensive portfolio, distribution network and supply chain is equaled only by our dedicated, knowledgeable people who deliver unrivalled expertise and unmatched customer service and support.

Learn more: pattersoncompanies.com

This press release contains, and our officers and representatives may from time to time make, certain “forward-looking statements” within the meaning of the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, including statements regarding future financial performance, and the objectives and expectations of management. Forward-looking statements often include words such as “believes,” “expects,” “anticipates,” “estimates,” “intends,” “plans,” “seeks” or words of similar meaning, or future or conditional verbs, such as “will,” “should,” “could” or “may.”

Forward-looking statements are neither historical facts nor assurances of future performance. Instead, they are based only on our current beliefs, expectations and assumptions regarding the future of our business, future plans and strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent uncertainties, risks and changes in circumstances that are difficult to predict and many of which are outside of our control. Our actual results and financial condition may differ materially from those indicated in the forward-looking statements. Therefore, you should not place undue reliance on any of these forward-looking statements.

Any number of factors could affect our actual results and cause such results to differ materially from those contemplated by any forward-looking statements, including, but not limited to, the following: the COVID-19 pandemic and measures taken in response thereto; uncertain macro-economic conditions, including inflationary pressures; our dependence on relationships with sales representatives and service technicians to retain customers and develop business; potential disruption of distribution capabilities, including service issues with third-party shippers; our dependence on suppliers to manufacture and supply substantially all of the products we sell; the risk of the products we sell becoming obsolete or containing undetected errors; adverse changes in supplier rebates or other purchasing incentives; the risk that private label sales could adversely affect our relationships with suppliers; our dependence on positive perceptions of Patterson’s reputation; risks inherent in acquiring and disposing of assets or other businesses and the risks inherent in integrating acquired businesses; our ability to comply with restrictive covenants in our credit agreement; turnover or loss of key personnel or highly skilled employees; the risk that our governing documents and Minnesota law may discourage takeovers and business combinations; risks related to climate change; the effects of the highly competitive and consolidating dental and animal health supply markets in which we compete; exposure to the risks of the animal production business, including changing consumer demand, the cyclical livestock market, and other factors outside our control, and the risks of the companion animal business, including the possibility of disease adversely affecting the pet population; risks from the formation or expansion of GPOs, provider networks and buying groups that may shift purchasing decisions and place us at a competitive disadvantage; increases in over-the-counter sales and e-commerce options for companion animal products or sales of companion animal products from non-veterinarian sources; change and uncertainty in the health care industry; failure to comply with existing or future U.S. or foreign laws and regulations including those governing the distribution of pharmaceuticals and controlled substances; failure to comply with health care fraud or other laws and regulations; litigation risks, including the diversion of management’s attention, the cost of defending against such actions, the possibility of damage awards or settlements, fines or penalties, or equitable remedies (including but not limited to the revocation of or non-renewal of licenses) and inherent uncertainty; failure to comply with evolving data privacy laws and regulations; tax legislation; the risks inherent in international operations, including currency fluctuations; and risks associated with information systems, software products and cyber-security attacks.

The order in which these factors appear should not be construed to indicate their relative importance or priority. We caution that these factors may not be exhaustive, accordingly, any forward-looking statements contained herein should not be relied upon as a prediction of actual results.

You should carefully consider these and other relevant factors, including those risk factors in Part I, Item 1A, (“Risk Factors”) in our most recent Form 10-K and information which may be contained in our other filings with the U.S. Securities and Exchange Commission, or SEC, when reviewing any forward-looking statement.

Investors should understand it is impossible to predict or identify all such factors or risks. As such, you should not consider the foregoing list, or the risks identified in our SEC filings, to be a complete discussion of all potential risks or uncertainties.

Any forward-looking statement made by us in this press release is based only on information currently available to us and speaks only as of the date on which it is made. We do not undertake any obligation to release publicly any revisions to any forward-looking statements whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise.

 

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except per share amounts)

(Unaudited)

 

Three Months Ended

 

Nine Months Ended

 

January 28, 2023

 

January 29, 2022

 

January 28, 2023

 

January 29, 2022

 

 

 

 

 

 

 

 

Net sales

$

1,600,850

 

 

$

1,596,596

 

 

$

4,750,319

 

 

$

4,860,633

 

 

 

 

 

 

 

 

 

Gross profit

 

342,962

 

 

 

336,611

 

 

 

983,184

 

 

 

940,848

 

 

 

 

 

 

 

 

 

Operating expenses

 

267,040

 

 

 

275,778

 

 

 

812,323

 

 

 

856,684

 

 

 

 

 

 

 

 

 

Operating income

 

75,922

 

 

 

60,833

 

 

 

170,861

 

 

 

84,164

 

 

 

 

 

 

 

 

 

Other income (expense):

 

 

 

 

 

 

 

Gains on investments

 

 

 

 

13,092

 

 

 

 

 

 

100,919

 

Other income, net

 

3,096

 

 

 

6,186

 

 

 

23,079

 

 

 

14,413

 

Interest expense

 

(9,731

)

 

 

(4,879

)

 

 

(22,838

)

 

 

(15,595

)

 

 

 

 

 

 

 

 

Income before taxes

 

69,287

 

 

 

75,232

 

 

 

171,102

 

 

 

183,901

 

 

 

 

 

 

 

 

 

Income tax expense

 

15,440

 

 

 

18,657

 

 

 

39,346

 

 

 

45,586

 

 

 

 

 

 

 

 

 

Net income

 

53,847

 

 

 

56,575

 

 

 

131,756

 

 

 

138,315

 

Net loss attributable to noncontrolling interests

 

(82

)

 

 

(431

)

 

 

(836

)

 

 

(1,017

)

Net income attributable to Patterson Companies, Inc.

$

53,929

 

 

$

57,006

 

 

$

132,592

 

 

$

139,332

 

 

 

 

 

 

 

 

 

Earnings per share attributable to Patterson Companies, Inc.:

 

 

 

 

 

 

 

Basic

$

0.55

 

 

$

0.58

 

 

$

1.37

 

 

$

1.43

 

 

 

 

 

 

 

 

 

Diluted

$

0.55

 

 

$

0.58

 

 

$

1.35

 

 

$

1.42

 

 

 

 

 

 

 

 

 

Weighted average shares:

 

 

 

 

 

 

 

Basic

 

97,327

 

 

 

97,471

 

 

 

96,957

 

 

 

97,213

 

Diluted

 

97,977

 

 

 

98,554

 

 

 

97,881

 

 

 

98,450

 

 

 

 

 

 

 

 

 

Dividends declared per common share

$

0.26

 

 

$

0.26

 

 

$

0.78

 

 

$

0.78 

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands)

(Unaudited)

 

January 28, 2023

 

April 30, 2022

 

 

 

 

ASSETS

 

 

 

Current assets:

 

 

 

Cash and cash equivalents

$

147,290

 

$

142,014

Receivables, net

 

422,715

 

 

447,162

Inventory

 

939,098

 

 

785,604

Prepaid expenses and other current assets

 

335,611

 

 

304,242

Total current assets

 

1,844,714

 

 

1,679,022

Property and equipment, net

 

213,770

 

 

213,140

Operating lease right-of-use assets, net

 

74,783

 

 

70,722

Goodwill and identifiable intangibles, net

 

397,780

 

 

393,244

Investments

 

159,365

 

 

139,182

Long-term receivables, net and other

 

251,579

 

 

246,320

Total assets

$

2,941,991

 

$

2,741,630

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

Current liabilities:

 

 

 

Accounts payable

$

702,456

 

$

681,321

Other accrued liabilities

 

232,187

 

 

276,000

Operating lease liabilities

 

28,063

 

 

29,348

Current maturities of long-term debt

 

36,000

 

 

Borrowings on revolving credit

 

175,000

 

 

29,000

Total current liabilities

 

1,173,706

 

 

1,015,669

Long-term debt

 

451,910

 

 

488,554

Non-current operating lease liabilities

 

48,989

 

 

43,332

Other non-current liabilities

 

164,965

 

 

151,440

Total liabilities

 

1,839,570

 

 

1,698,995

Stockholders' equity

 

1,102,421

 

 

1,042,635

Total liabilities and stockholders' equity

$

2,941,991

 

$

2,741,630

PATTERSON COMPANIES, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

 

Nine Months Ended

 

January 28, 2023

 

January 29, 2022

 

 

 

 

Operating activities:

 

 

 

Net income

$

131,756

 

 

$

138,315

 

Adjustments to reconcile net income to net cash used in operating activities:

 

 

 

Depreciation and amortization

 

62,298

 

 

 

61,405

 

Gains on investments

 

 

 

 

(100,919

)

Non-cash employee compensation

 

11,349

 

 

 

18,384

 

Non-cash losses (gains) and other, net

 

7,227

 

 

 

5,815

 

Change in assets and liabilities:

 

 

 

Receivables

 

(729,039

)

 

 

(850,628

)

Inventory

 

(155,184

)

 

 

(132,689

)

Accounts payable

 

20,947

 

 

 

110,862

 

Accrued liabilities

 

(40,909

)

 

 

(49,296

)

Other changes from operating activities, net

 

(36,642

)

 

 

(35,388

)

Net cash used in operating activities

 

(728,197

)

 

 

(834,139

)

Investing activities:

 

 

 

Additions to property and equipment

 

(42,442

)

 

 

(26,488

)

Collection of deferred purchase price receivables

 

758,001

 

 

 

918,354

 

Payments related to acquisitions, net of cash acquired

 

(33,257

)

 

 

(19,793

)

Payments related to investments

 

(15,000

)

 

 

 

Sale of investments

 

 

 

 

74,346

 

Net cash provided by investing activities

 

667,302

 

 

 

946,419

 

Financing activities:

 

 

 

Dividends paid

 

(75,954

)

 

 

(75,746

)

Repurchases of common stock

 

(15,000

)

 

 

 

Payments on long-term debt

 

 

 

 

(100,750

)

Draw on revolving credit

 

146,000

 

 

 

82,000

 

Other financing activities

 

12,866

 

 

 

4,030

 

Net cash provided by (used in) financing activities

 

67,912

 

 

 

(90,466

)

Effect of exchange rate changes on cash

 

(1,741

)

 

 

(14

)

Net change in cash and cash equivalents

 

5,276

 

 

 

21,800

 

Cash and cash equivalents at beginning of period

 

142,014

 

 

 

143,244

 

Cash and cash equivalents at end of period

$

147,290

 

 

$

165,044

 

PATTERSON COMPANIES, INC.

SALES SUMMARY

(Dollars in thousands)

(Unaudited)

 

January 28, 2023

 

January 29, 2022

 

Total

Sales

Growth

 

Foreign

Exchange

Impact

 

53rd Week

 

Acquisition Impact

 

Internal Sales

Growth

Three Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated net sales

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumable

$

1,250,859

 

$

1,237,127

 

1.1

%

 

(1.8

)%

 

%

 

0.1

%

 

2.8

%

Equipment and software

 

252,671

 

 

276,446

 

(8.6

)

 

(0.5

)

 

 

 

 

 

(8.1

)

Value-added services and other

 

97,320

 

 

83,023

 

17.2

 

 

(1.4

)

 

 

 

0.9

 

 

17.7

 

Total

$

1,600,850

 

$

1,596,596

 

0.3

%

 

(1.6

)%

 

%

 

0.1

%

 

1.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dental

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumable

$

330,199

 

$

337,192

 

(2.1

)%

 

(0.6

)%

 

%

 

%

 

(1.5

)%

Equipment and software

 

216,642

 

 

241,384

 

(10.3

)

 

(0.6

)

 

 

 

 

 

(9.7

)

Value-added services and other

 

74,955

 

 

72,057

 

4.0

 

 

(0.5

)

 

 

 

 

 

4.5

 

Total

$

621,796

 

$

650,633

 

(4.4

)%

 

(0.6

)%

 

%

 

%

 

(3.8

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Animal Health

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumable

$

920,660

 

$

899,935

 

2.3

%

 

(2.3

)%

 

%

 

0.2

%

 

4.4

%

Equipment and software

 

36,029

 

 

35,062

 

2.8

 

 

 

 

 

 

 

 

2.8

 

Value-added services and other

 

12,689

 

 

9,777

 

29.8

 

 

(8.6

)

 

 

 

7.4

 

 

31.0

 

Total

$

969,378

 

$

944,774

 

2.6

%

 

(2.2

)%

 

%

 

0.2

%

 

4.6

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

 

 

 

 

 

 

 

 

 

Value-added services and other

$

9,676

 

$

1,189

 

713.8

%

 

%

 

%

 

%

 

713.8

%

Total

$

9,676

 

$

1,189

 

713.8

%

 

%

 

%

 

%

 

713.8

%

PATTERSON COMPANIES, INC.

SALES SUMMARY

(Dollars in thousands)

(Unaudited)

 

January 28, 2023

 

January 29, 2022

 

Total

Sales

Growth

 

Foreign

Exchange

Impact

 

53rd Week

 

Acquisition Impact

 

Internal Sales

Growth

Nine Months Ended

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Consolidated net sales

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumable

$

3,813,884

 

$

3,923,613

 

(2.8

)%

 

(2.0

)%

 

(2.5

)%

 

0.1

%

 

1.6

%

Equipment and software

 

670,502

 

 

683,711

 

(1.9

)

 

(0.5

)

 

(1.8

)

 

 

 

0.4

 

Value-added services and other

 

265,933

 

 

253,309

 

5.0

 

 

(1.6

)

 

(2.0

)

 

0.3

 

 

8.3

 

Total

$

4,750,319

 

$

4,860,633

 

(2.3

)%

 

(1.8

)%

 

(2.4

)%

 

0.1

%

 

1.8

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Dental

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumable

$

1,005,528

 

$

1,070,422

 

(6.1

)%

 

(0.5

)%

 

(2.5

)%

 

%

 

(3.1

)%

Equipment and software

 

577,158

 

 

591,787

 

(2.5

)

 

(0.6

)

 

(1.7

)

 

 

 

(0.2

)

Value-added services and other

 

225,950

 

 

217,506

 

3.9

 

 

(0.4

)

 

(1.9

)

 

 

 

6.2

 

Total

$

1,808,636

 

$

1,879,715

 

(3.8

)%

 

(0.5

)%

 

(2.2

)%

 

%

 

(1.1

)%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Animal Health

 

 

 

 

 

 

 

 

 

 

 

 

 

Consumable

$

2,808,356

 

$

2,853,191

 

(1.6

)%

 

(2.6

)%

 

(2.5

)%

 

0.2

%

 

3.3

%

Equipment and software

 

93,344

 

 

91,924

 

1.5

 

 

 

 

(2.2

)

 

 

 

3.7

 

Value-added services and other

 

31,044

 

 

29,916

 

3.8

 

 

(10.6

)

 

(2.9

)

 

2.3

 

 

15.0

 

Total

$

2,932,744

 

$

2,975,031

 

(1.4

)%

 

(2.6

)%

 

(2.5

)%

 

0.2

%

 

3.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Corporate

 

 

 

 

 

 

 

 

 

 

 

 

 

Value-added services and other

$

8,939

 

$

5,887

 

51.8

%

 

%

 

%

 

%

 

51.8

%

Total

$

8,939

 

$

5,887

 

51.8

%

 

%

 

%

 

%

 

51.8

%

 

PATTERSON COMPANIES, INC.

OPERATING INCOME BY SEGMENT

(In thousands)

(Unaudited)

 

Three Months Ended

 

Nine Months Ended

 

January 28, 2023

 

January 29, 2022

 

January 28, 2023

 

January 29, 2022

 

 

 

 

 

 

 

 

Operating income (loss)

 

 

 

 

 

 

 

Dental

$

60,302

 

 

$

64,125

 

 

$

158,147

 

 

$

118,609

 

Animal Health

 

30,197

 

 

 

23,420

 

 

 

80,372

 

 

 

73,360

 

Corporate

 

(14,577

)

 

 

(26,712

)

 

 

(67,658

)

 

 

(107,805

)

Total

$

75,922

 

 

$

60,833

 

 

$

170,861

 

 

$

84,164

 

PATTERSON COMPANIES, INC.

RECONCILIATION OF GAAP TO NON-GAAP MEASURES

(Dollars in thousands, except per share amounts)

(Unaudited)

For the three months ended January 28, 2023

 

GAAP

 

Deal amortization

 

Integration and business restructuring expenses

 

Legal reserves

 

Inventory donation charges

 

Gains on investments

 

Non-GAAP

Operating income

 

$

75,922

 

 

$

9,482

 

$

 

$

 

$

 

$

 

 

$

85,404

 

Other income (expense), net

 

 

(6,635

)

 

 

 

 

 

 

 

 

 

 

 

 

 

(6,635

)

Income before taxes

 

 

69,287

 

 

 

9,482

 

 

 

 

 

 

 

 

 

 

 

78,769

 

Income tax expense

 

 

15,440

 

 

 

2,272

 

 

 

 

 

 

 

 

 

 

 

17,712

 

Net income

 

 

53,847

 

 

 

7,210

 

 

 

 

 

 

 

 

 

 

 

61,057

 

Net loss attributable to noncontrolling interests

 

 

(82

)

 

 

 

 

 

 

 

 

 

 

 

 

 

(82

)

Net income attributable to Patterson Companies, Inc.

 

$

53,929

 

 

$

7,210

 

$

 

$

 

$

 

$

 

 

$

61,139

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share attributable to Patterson Companies, Inc.*

 

$

0.55

 

 

$

0.07

 

$

 

$

 

$

 

$

 

 

$

0.62

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income as a % of sales

 

 

4.7

%

 

 

 

 

 

 

 

 

 

 

 

 

5.3

%

Effective tax rate

 

 

22.3

%

 

 

 

 

 

 

 

 

 

 

 

 

22.5

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the three months ended January 29, 2022

 

GAAP

 

Deal amortization

 

Integration and business restructuring expenses

 

Legal reserves

 

Inventory donation charges

 

Gains on investments

 

Non-GAAP

Operating income

 

$

60,833

 

 

$

9,252

 

$

 

$

 

$

 

$

 

 

$

70,085

 

Other income (expense), net

 

 

14,399

 

 

 

 

 

 

 

 

 

 

 

(13,092

)

 

 

1,307

 

Income before taxes

 

 

75,232

 

 

 

9,252

 

 

 

 

 

 

 

 

(13,092

)

 

 

71,392

 

Income tax expense

 

 

18,657

 

 

 

2,247

 

 

 

 

 

 

 

 

(3,273

)

 

 

17,631

 

Net income

 

 

56,575

 

 

 

7,005

 

 

 

 

 

 

 

 

(9,819

)

 

 

53,761

 

Net loss attributable to noncontrolling interests

 

 

(431

)

 

 

 

 

 

 

 

 

 

 

 

 

 

(431

)

Net income attributable to Patterson Companies, Inc.

 

$

57,006

 

 

$

7,005

 

$

 

$

 

$

 

$

(9,819

)

 

$

54,192

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share attributable to Patterson Companies, Inc.*

 

$

0.58

 

 

$

0.07

 

$

 

$

 

$

 

$

(0.10

)

 

$

0.55

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income as a % of sales

 

 

3.8

%

 

 

 

 

 

 

 

 

 

 

 

 

4.4

%

Effective tax rate

 

 

24.8

%

 

 

 

 

 

 

 

 

 

 

 

 

24.7

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

* May not sum due to rounding

 

 

 

 

 

 

 

 

 

 

 

 

 

 

PATTERSON COMPANIES, INC.

RECONCILIATION OF GAAP TO NON-GAAP MEASURES

(Dollars in thousands, except per share amounts)

(Unaudited)

For the nine months ended January 28, 2023

 

GAAP

 

Deal amortization

 

Integration and business restructuring expenses

 

Legal reserves

 

Inventory donation charges

 

Gains on investments

 

Non-GAAP

Operating income

 

$

170,861

 

 

$

28,160

 

$

 

$

 

$

 

$

 

 

$

199,021

 

Other income (expense), net

 

 

241

 

 

 

 

 

 

 

 

 

 

 

 

 

 

241

 

Income before taxes

 

 

171,102

 

 

 

28,160

 

 

 

 

 

 

 

 

 

 

 

199,262

 

Income tax expense

 

 

39,346

 

 

 

6,746

 

 

 

 

 

 

 

 

 

 

 

46,092

 

Net income

 

 

131,756

 

 

 

21,414

 

 

 

 

 

 

 

 

 

 

 

153,170

 

Net loss attributable to noncontrolling interests

 

 

(836

)

 

 

 

 

 

 

 

 

 

 

 

 

 

(836

)

Net income attributable to Patterson Companies, Inc.

 

$

132,592

 

 

$

21,414

 

$

 

$

 

$

 

$

 

 

$

154,006

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share attributable to Patterson Companies, Inc.*

 

$

1.35

 

 

$

0.22

 

$

 

$

 

$

 

$

 

 

$

1.57

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income as a % of sales

 

 

3.6

%

 

 

 

 

 

 

 

 

 

 

 

 

4.2

%

Effective tax rate

 

 

23.0

%

 

 

 

 

 

 

 

 

 

 

 

 

23.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

For the nine months ended January 29, 2022

 

GAAP

 

Deal amortization

 

Integration and business restructuring expenses

 

Legal reserves

 

Inventory donation charges

 

Gains on investments

 

Non-GAAP

Operating income

 

$

84,164

 

 

$

28,407

 

$

4,245

 

$

36,000

 

$

49,194

 

$

 

 

$

202,010

 

Other income (expense), net

 

 

99,737

 

 

 

 

 

 

 

 

 

 

 

(100,919

)

 

 

(1,182

)

Income before taxes

 

 

183,901

 

 

 

28,407

 

 

4,245

 

 

36,000

 

 

49,194

 

 

(100,919

)

 

 

200,828

 

Income tax expense

 

 

45,586

 

 

 

6,753

 

 

1,061

 

 

8,460

 

 

12,308

 

 

(25,669

)

 

 

48,499

 

Net income

 

 

138,315

 

 

 

21,654

 

 

3,184

 

 

27,540

 

 

36,886

 

 

(75,250

)

 

 

152,329

 

Net loss attributable to noncontrolling interests

 

 

(1,017

)

 

 

 

 

 

 

 

 

 

 

 

 

 

(1,017

)

Net income attributable to Patterson Companies, Inc.

 

$

139,332

 

 

$

21,654

 

$

3,184

 

$

27,540

 

$

36,886

 

$

(75,250

)

 

$

153,346

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Diluted earnings per share attributable to Patterson Companies, Inc.*

 

$

1.42

 

 

$

0.22

 

$

0.03

 

$

0.28

 

$

0.37

 

$

(0.76

)

 

$

1.56

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating income as a % of sales

 

 

1.7

%

 

 

 

 

 

 

 

 

 

 

 

 

4.2

%

Effective tax rate

 

 

24.8

%

 

 

 

 

 

 

 

 

 

 

 

 

24.1

%

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

* May not sum due to rounding

 

 

 

 

 

 

 

 

 

 

 

 

PATTERSON COMPANIES, INC.

FREE CASH FLOW

(In thousands)

(Unaudited)

 

Nine Months Ended

 

January 28, 2023

 

January 29, 2022

Net cash used in operating activities

$

(728,197

)

 

$

(834,139

)

Additions to property and equipment

 

(42,442

)

 

 

(26,488

)

Collection of deferred purchase price receivables

 

758,001

 

 

 

918,354

 

Free cash flow

$

(12,638

)

 

$

57,727

 

 

 

 

 

 

Contacts

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
Copyright © 2010-2020 Burlingame.com & California Media Partners, LLC. All rights reserved.